Back

SARS-CoV-2 B.1.351 (beta) variant shows enhanced infectivity in K18-hACE2 transgenic mice and expanded tropism to wildtype mice compared to B.1 variant

Tarres-Freixas, F.; Trinite, B.; Pons-Grifols, A.; Romero-Durana, M.; Riveira-Munoz, E.; Avila-Nieto, C.; Perez, M.; Garcia-Vidal, E.; Perez-Zsolt, D.; Munoz-Basagoiti, J.; Raich-Regue, D.; Izquierdo-Useros, N.; Blanco, I.; Noguera-Julian, M.; Guallar, V.; Lepore, R.; Valencia, A.; Vergara-Alert, J.; Clotet, B.; Ballana, E.; Carrillo, J.; Segales, J.; Blanco, J.

2021-08-03 microbiology
10.1101/2021.08.03.454861 bioRxiv
Show abstract

SARS-CoV-2 variants display enhanced transmissibility and/or immune evasion and can be generated in humans or animals, like minks, thus generating new reservoirs. The continuous surveillance of animal susceptibility to new variants is necessary to predict pandemic evolution. In this study we demonstrate that, compared to the B.1 SARS-CoV-2 variant, K18-hACE2 transgenic mice challenged with the B.1.351 variant displayed a faster progression of infection. Furthermore, we also report that B.1.351 can establish infection in wildtype mice, while B.1 cannot. B.1.351-challenged wildtype mice showed a milder infection than transgenic mice, confirmed by detectable viral loads in oropharyngeal swabs and tissues, lung pathology, immunohistochemistry and serology. In silico models supported these findings by demonstrating that the Spike mutations in B.1.351 resulted in increased affinity for both human and murine ACE2 receptors. Overall, this study highlights the plasticity of SARS-CoV-2 animal susceptibility landscape, which may contribute to viral persistence and expansion.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.